Xiidra and Restasis are prescription eye drops used to treat chronic dry eye disease. They both are characterized by high-quality composition, strong effectiveness, and easy application. In this article, you will be able to check out detailed information on these prescription medications to ...

Breaking news in dry eye disease treatment, the U.S. Food and Drug Administration (FDA) has approved the first generic version of Restasis, cyclosporine ophthalmic emulsion 0.05%. This milestone, headed by Mylan Pharmaceuticals Inc., is poised to redefine the landscape of dry eye treatment. ...